2007 Food and Drug Administration Pharmaceutical research 
PM360
NOVEMBER 12, 2024
They are difficult to diagnose early in a disease, the regulatory endpoints are often unprecedented and challenging, and many drugs struggle to get into the brain. The downside is that it also keeps most potential drug treatments from reaching the brain. Before Sage, he served as president of Alnylam Pharmaceuticals, Inc.
Pharmaceutical Technology
SEPTEMBER 10, 2008
Now the company is a GLP-certified contract research organisation that focuses on three main domains. Firstly, there is a comprehensive toxicological service for human and veterinary pharmaceuticals and biopharmaceuticals, food additives, chemicals and agrochemicals. Can you reveal the results of these?
Expert insights. Personalized for you.
52 
Let's personalize your content